MGMT, which removes alkyl groups from the O6 position of guanine thereby repairing DNA damage caused by alkylating agents like temozolomide, has been shown to be an important prognostic variable in pediatric GBM (Donson et al., 2007). Here, MGMT is linked to glioblastoma.